Annane Djillali, Aegerter Philippe, Jars-Guincestre Marie Claude, Guidet Bertrand
Service de Réanimation Médicale, Hôpital Raymond Poincaré, Faculté de Médecine Paris Ile de France Ouest, Université de Versaille Saint Quentinen-Yvelinnes, 104, Boulevard Raymond Poincaré, 92380 Garches, France.
Am J Respir Crit Care Med. 2003 Jul 15;168(2):165-72. doi: 10.1164/rccm.2201087.
To update the epidemiology of septic shock we analyzed clinical, microbiologic, and outcome variables from 100,554 intensive care unit admissions on the Collège des Utilisateurs de Bases de données en Réanimation (CUB-Réa) database, collected from 22 hospitals over a 8-year period, 1993 to 2000. The overall frequency of septic shock was 8.2 per 100 admissions (i.e., 8,251 stays). It increased from 7.0 (in 1993) to 9.7 per 100 admissions (in 2000). The distribution analysis of the sites of infection and of the types of pathogens showed an increase in the rate of pulmonary infection (p = 0.001) and of multiresistant bacteria-related septic shock (p = 0.001). The crude mortality was 60.1% and declined from 62.1% (in 1993) to 55.9 (in 2000) (p = 0.001). As compared with matched intensive care unit admissions without sepsis, the excess risk of death due to septic shock was 25.7 (95% confidence interval, 24.0-27.3) and the matched odds ratio of death was 3.9 (95% confidence interval, 3.5-4.3). The frequency of septic shock is increasing with more multiresistant strains. Its crude mortality rate is decreasing, but patients with septic shock still have a high excess risk of death than critically ill patients who are nonseptic.
为更新感染性休克的流行病学情况,我们分析了法国重症监护数据库使用者协会(CUB - Réa)数据库中100554例重症监护病房入院病例的临床、微生物学及转归变量,这些数据是在1993年至2000年的8年期间从22家医院收集的。感染性休克的总体发生率为每100例入院病例中有8.2例(即8251例住院病例)。其发生率从1993年的每100例中有7.0例增至2000年的每100例中有9.7例。感染部位及病原体类型的分布分析显示肺部感染率(p = 0.001)及多重耐药菌相关感染性休克发生率(p = 0.001)均有所增加。粗死亡率为60.1%,并从1993年的62.1%降至2000年的55.9%(p = 0.001)。与未发生脓毒症的匹配重症监护病房入院病例相比,感染性休克导致的额外死亡风险为25.7(95%置信区间为24.0 - 27.3),死亡的匹配比值比为3.9(95%置信区间为3.5 - 4.3)。随着多重耐药菌株增多,感染性休克的发生率在上升。其粗死亡率在下降,但感染性休克患者的额外死亡风险仍高于非脓毒症的重症患者。